Skip to main content
M

Megi

Megi offers an AI‑driven platform that predicts a woman's risk of preeclampsia early in pregnancy and provides continuous postpartum monitoring to flag elevated cardiovascular risk. By integrating with obstetric and cardiology workflows and EHR systems, it delivers personalized risk scores, actionable insights, and a seamless transition to lifelong heart‑health management for women.

London, United KingdomFounded 2022122K+ followers
Updated 2 months ago

Funding

Funding not disclosed

AO
Funding rounds are not available yet.

Founders

Product

Problem

Many pregnant women develop preeclampsia, a hypertension‑related condition that is a leading cause of maternal mortality and signals a higher lifetime risk of cardiovascular disease. Traditional prenatal care often detects preeclampsia only after symptoms appear, and postpartum follow‑up is unstructured, leaving women vulnerable to ongoing heart‑health risks.

Solution

Megi provides an AI‑driven platform that predicts a woman's risk of developing preeclampsia before clinical signs emerge. The system continues to monitor patients after delivery, offering structured postpartum surveillance when cardiovascular risk remains elevated. By linking pregnancy‑stage risk assessment to a lifelong heart‑health care pathway, Megi enables early intervention and preventive management for women at all stages of their reproductive and post‑reproductive lives. The platform leverages exclusive longitudinal clinical datasets from pregnant cohorts to refine its predictive models and supports seamless integration into existing obstetric and cardiology workflows.

Target Audience

Primary customers are obstetricians, maternal‑fetal medicine specialists, and healthcare systems seeking to improve prenatal and postpartum care, as well as cardiologists and primary‑care providers focused on long‑term cardiovascular risk management for women.

Features

  • Machine‑learning algorithms trained on unique longitudinal data to generate individualized preeclampsia risk scores early in pregnancy
  • Continuous postpartum risk monitoring with alerts for elevated cardiovascular risk during the critical post‑delivery period
  • Integrated care pathway that transitions patients from pregnancy monitoring to long‑term heart‑health management
  • Clinician dashboard presenting risk trends, actionable insights, and recommended preventive actions
  • Compatibility with electronic health record (EHR) systems for automated data exchange and documentation
  • Compliance with healthcare and data‑security standards to protect patient information
This profile is AI-generated and may contain inaccuracies.